Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+57.0%
5Y CAGR+58.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+57.0%/yr
vs +16.0%/yr prior
5Y CAGR
+58.4%/yr
Consistent
Acceleration
+41.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $84.45M | +69.0% |
| 2024 | $49.97M | +37.1% |
| 2023 | $36.45M | +67.1% |
| 2022 | $21.82M | +60.8% |
| 2021 | $13.57M | +60.5% |
| 2020 | $8.46M | +64.5% |
| 2019 | $5.14M | -57.4% |
| 2018 | $12.07M | +12.1% |
| 2017 | $10.77M | -32.9% |
| 2016 | $16.04M | - |